杰士邦股东据悉拟出售少数股权
Xin Lang Cai Jing·2025-10-10 09:15
Group 1 - Investors, including Hillhouse Capital and Renfu Pharmaceutical Group, are exploring the sale of approximately 20%-30% of their stake in Jissbon [1] - Ongoing discussions are taking place with potential buyers such as CVC Capital Partners and Anhong Capital [1] - There is a possibility that no transaction will be reached as negotiations are still in progress [1]